REVIEW

Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review

J Avouac, L Gossec, M Dougados

René Descartes University, Medicine Faculty; APHP Cochin Hospital, Rheumatology B Department, Paris, France

Correspondence to:
Professor M Dougados
Rhumatologie B, Hôpital Cochin, 27 rue du Faubourg Saint-Jacques, 75014 Paris, France; maxime.dougados{at}cch.aphp.fr

Objective: To evaluate the two generations of anti-cyclic citrullinated protein (CCP) antibodies as a diagnostic marker of rheumatoid arthritis (RA) and as a predictor of future development of RA in healthy subjects and in patients with early undifferentiated arthritis.

Methods: A systematic analysis of the literature published between 1999 and February 2006 was conducted. Data were collected on the sensitivity and specificity of the two generations of anti-CCP antibodies for diagnosing RA and predicting future development of the disease.

Results: Among 107 studies initially identified, 68 had interpretable data and were analysed. Diagnostic properties were assessed in 58 studies: mean (SD) sensitivity was 53 (10)% (range 41–68) and 68 (15)% (range 39–94) for anti-CCP1 and anti-CCP2, respectively; mean (SD) specificity was 96 (3)% (range 90–99) and 95 (5)% (range 81–100) for anti-CCP1 and anti-CCP2, respectively. Predictive properties were assessed in 14 studies; odds ratio (95% confidence interval) of anti-CCP1 and anti-CCP2 for the future development of RA were 20 (14 to 31) and 25 (18 to 35), respectively, among patients with early undifferentiated arthritis and 64.5 (8.5 to 489) and 28 (8 to 95), respectively, among healthy subjects.

Conclusion: Sensitivity of the second generation of anti-CCP is close to that of rheumatoid factor, with a higher specificity, for distinguishing RA from other rheumatic diseases. Moreover, anti-CCP antibodies appear to be highly predictive of the future development of RA in both healthy subjects and patients with undifferentiated arthritis.

Abbreviations: ACR, American College of Rheumatology; CCP, cyclic citrullinated protein; CI, confidence interval; RA, rheumatoid arthritis

Keywords: rheumatoid arthritis; anti-CCP antibodies; diagnosis; predictive marker; serological marker

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Song, Y.W., Kang, E.H. (2009). Autoantibodies in rheumatoid arthritis: rheumatoid factors and anticitrullinated protein antibodies. QJM 0: hcp165v1-hcp165 [Abstract] [Full Text]  
• Dayer, J.-M., Choy, E. (2009). Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor. Rheumatology (Oxford) 0: kep329v1-kep329 [Abstract] [Full Text]  
• Qing, Y-F, Zhang, Q-B, Zhou, J-G, Yuan, G-H, Wei, J, Xing, Y, Liu, J-P, Jiang, L, Chen, J-P (2009). The detecting and clinical value of anti-cyclic citrullinated peptide antibodies in patients with systemic lupus erythematosus. Lupus 18: 713-717 [Abstract]  
• Banal, F, Dougados, M, Combescure, C, Gossec, L (2009). Sensitivity and specificity of the American College of Rheumatology 1987 criteria for the diagnosis of rheumatoid arthritis according to disease duration: a systematic literature review and meta-analysis. Ann Rheum Dis 68: 1184-1191 [Abstract] [Full Text]  
• Labrador-Horrillo, M., Martinez, M{a} A., Selva-O'Callaghan, A., Delgado, J. F., Martinez-Gomez, X., Trallero-Araguas, E., Rodriguez-Sanchez, J. L., Vilardell-Tarres, M. (2009). Anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with idiopathic inflammatory myopathy. Rheumatology (Oxford) 48: 676-679 [Abstract] [Full Text]  
• Shmerling, R. H. (2009). Testing for Anti-Cyclic Citrullinated Peptide Antibodies: Is It Time to Set This Genie Free?. Arch Intern Med 169: 9-14 [Full Text]  
• Loos, T., Mortier, A., Gouwy, M., Ronsse, I., Put, W., Lenaerts, J.-P., Van Damme, J., Proost, P. (2008). Citrullination of CXCL10 and CXCL11 by peptidylarginine deiminase: a naturally occurring posttranslational modification of chemokines and new dimension of immunoregulation. Blood 112: 2648-2656 [Abstract] [Full Text]  
• Dasgupta, B, Hutchings, A, Hollywood, J, Nutter, L (2008). Autoantibodies to cyclic citrullinated peptide in a PMR inception cohort from The PMR Outcomes Study. Ann Rheum Dis 67: 903-904 [Full Text]  
• Jorgensen, K T, Wiik, A, Pedersen, M, Hedegaard, C J, Vestergaard, B F, Gislefoss, R E, Kvien, T K, Wohlfahrt, J, Bendtzen, K, Frisch, M (2008). Cytokines, autoantibodies and viral antibodies in premorbid and postdiagnostic sera from patients with rheumatoid arthritis: case-control study nested in a cohort of Norwegian blood donors. Ann Rheum Dis 67: 860-866 [Abstract] [Full Text]  
• Madan, A., Belshaw, R., Grennan, D. (2007). Anti-CCP antibodies as an aid to prioritization of patients referred to the rheumatology clinic. QJM 100: 737-738 [Full Text]  
• Aigner, E, Schmid, I, Osterreicher, C H, Zwerina, J, Schett, G, Strasser, M, Niksic, F, Hohla, F, Ramsauer, T, Dorn, U, Patsch, W, Datz, C (2007). Contribution of anti-cyclic citrullinated peptide antibody and rheumatoid factor to the diagnosis of arthropathy in haemochromatosis. Ann Rheum Dis 66: 1249-1251 [Abstract] [Full Text]  
• Dubois-Galopin, F., Beauvillain, C., Dubois, D., Pillet, A., Renier, G., Jeannin, P., Masson, C., Chevailler, A. (2007). New markers and an old phenomenon: prozone effect disturbing detection of filaggrin (keratin) autoantibodies. Ann Rheum Dis 66: 1121-1122 [Full Text]  
• Bizzaro, N., Tonutti, E., Tozzoli, R., Villalta, D. (2007). Analytical and Diagnostic Characteristics of 11 2nd- and 3rd-Generation Immunoenzymatic Methods for the Detection of Antibodies to Citrullinated Proteins. Clin. Chem. 53: 1527-1533 [Abstract] [Full Text]  
• Finckh, A., Liang, M. H. (2007). Anti-Cyclic Citrullinated Peptide Antibodies in the Diagnosis of Rheumatoid Arthritis: Bayes Clears the Haze. ANN INTERN MED 146: 816-817 [Full Text]  
• Symmons, D. P. M. (2007). Classification criteria for rheumatoid arthritis--time to abandon rheumatoid factor?. Rheumatology (Oxford) 46: 725-726 [Full Text]  
• Coenen, D., Verschueren, P., Westhovens, R., Bossuyt, X. (2007). Technical and Diagnostic Performance of 6 Assays for the Measurement of Citrullinated Protein/Peptide Antibodies in the Diagnosis of Rheumatoid Arthritis. Clin. Chem. 53: 498-504 [Abstract] [Full Text]  
• Inanc, M. (2007). Very early 'Rheumatoid' arthritis cohorts: limited by selection. Rheumatology (Oxford) 46: 185-187 [Full Text]